{"gao_id": "GAO-12-116", "published": "2011-11-21T13:11:00Z", "released": "2011-12-15T08:12:00Z", "summary": "", "title": "Drug Shortages: FDA's Ability to Respond Should Be Strengthened", "topics": ["Decision making", "Supply chain management", "Drug pricing", "Professional ethics", "Inventory control systems", "Prices and pricing", "Prescription drugs", "Program evaluation", "Consolidation", "Strategic planning", "Generic drugs", "Patient care services", "Pharmaceutical industry", "Supply and demand", "Manufacturing industry", "Justice and Law Enforcement", "Reporting requirements", "Performance measures", "Public health"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-12-116", "versions": [{"title": "Highlights (1 page)", "url": "https://www.gao.gov/assets/gao-12-116-highlights.pdf"}, {"title": "Full Report (63 pages)", "url": "https://www.gao.gov/assets/gao-12-116.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/590/587049.txt"}]}